نتایج جستجو برای: peptide based vaccine

تعداد نتایج: 3159027  

Journal: : 2022

Background. The effectiveness of cancer neoantigen peptide vaccines depends on the presence an adjuvant in their composition. Poly(I:C), a TRL-3 agonist, is used as mouse models vaccines, but has limitations for use humans. Therefore, search new effective adjuvants inclusion composition vaccine relevant. Ridostin Pro domestic drug that contains natural complex sodium salts double-chiral and sin...

Journal: :Biomacromolecules 2013
Tzu-Yu Liu Waleed M Hussein Zhongfan Jia Zyta M Ziora Nigel A J McMillan Michael J Monteiro Istvan Toth Mariusz Skwarczynski

Dendrimers are structurally well-defined, synthetic polymers with sizes and physicochemical properties often resembling those of biomacromolecules (e.g., proteins). As a result, they are promising candidates for peptide-based vaccine delivery platforms. Herein, we established a synthetic pathway to conjugate a human papillomavirus (HPV) E7 protein-derived peptide antigen to a star-polymer to cr...

Journal: :Vaccine 2002
Chang Yi Wang Tseng Yuan Chang Alan M Walfield John Ye Ming Shen Shih Ping Chen Ming Chang Li Yeou Liang Lin Ming Hwa Jong Ping Cheng Yang Nancy Chyr Ed Kramer Fred Brown

We have designed a peptide-based vaccine for foot-and-mouth disease (FMD) effective in swine. The peptide immunogen has a G-H loop domain from the VP1 capsid protein of foot-and-mouth disease virus (FMDV) and a novel promiscuous T helper (Th) site for broad immunogenicity in multiple species. The G-H loop VP1 site was optimised for cross-reactivity to FMDV by the inclusion into the peptide of c...

2014
Sumiyuki Nishida Shigeo Koido Yutaka Takeda Sadamu Homma Hideo Komita Akitaka Takahara Satoshi Morita Toshinori Ito Soyoko Morimoto Kazuma Hara Akihiro Tsuboi Yoshihiro Oka Satoru Yanagisawa Yoichi Toyama Masahiro Ikegami Toru Kitagawa Hidetoshi Eguchi Hiroshi Wada Hiroaki Nagano Jun Nakata Yoshiki Nakae Naoki Hosen Yusuke Oji Toshio Tanaka Ichiro Kawase Atsushi Kumanogoh Junichi Sakamoto Yuichiro Doki Masaki Mori Toshifumi Ohkusa Hisao Tajiri Haruo Sugiyama

Wilms tumor gene (WT1) protein is an attractive target for cancer immunotherapy. We aimed to investigate the feasibility of a combination therapy consisting of gemcitabine and WT1 peptide-based vaccine for patients with advanced pancreatic cancer and to make initial assessments of its clinical efficacy and immunologic response. Thirty-two HLA-A*24:02 patients with advanced pancreatic cancer wer...

Journal: :Archives of otolaryngology--head & neck surgery 2006
Kristin B Gendron Alex Rodriguez Duane A Sewell

OBJECTIVE To test whether an E7 peptide/CpG vaccine is effective in preventing and treating human papillomavirus-positive tumors in a murine model. INTERVENTION First, an E7 peptide/CpG vaccine was administered systemically on days -14 and -7, and tumor cells were injected subcutaneously on day 0. Second, tumor cells were injected on day 0, and vaccine was administered on days 7, 14, and 21. ...

2013
Jordan V. Price Justin A. Jarrell David Furman Nicole H. Kattah Evan Newell Cornelia L. Dekker Mark M. Davis Paul J. Utz

BACKGROUND Existing methods to measure influenza vaccine immunogenicity prohibit detailed analysis of epitope determinants recognized by immunoglobulins. The development of highly multiplex proteomics platforms capable of capturing a high level of antibody binding information will enable researchers and clinicians to generate rapid and meaningful readouts of influenza-specific antibody reactivi...

2017
Lucy K. Shewell Freda E.-C Jen Michael P. Jennings

The emergence of multi-drug resistant Neisseria gonorrhoeae has generated an urgent need for novel therapies or a vaccine to prevent gonococcal disease. In this study we investigate the potential of targeting the surface exposed nitrite reductase, AniA, to block activity by producing functional blocking antibodies. AniA activity is essential for anaerobic growth and biofilm formation of N. gono...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 1999
M L Disis K H Grabstein P R Sleath M A Cheever

HER-2/neu is a "self" tumor antigen that is overexpressed in 15-30% of human adenocarcinomas. Vaccine strategies directed against HER-2/neu and other self tumor antigens require development of methods to overcome immune tolerance to self-proteins. In rats, rat neu peptide vaccines have been shown to be an effective way of circumventing tolerance to rat neu protein and generating rat neu-specifi...

2013
Mohan Karkada Tara Quinton Rachelle Blackman Marc Mansour

A successful cancer vaccine needs to overcome the effects of immune-suppressor cells such as Treg lymphocytes, suppressive cytokine-secreting Tr1 cells, and myeloid-derived suppressor cells (MDSCs), while enhancing tumor-specific immune responses. Given the relative poor efficacy associated with current cancer vaccines, a novel vaccine platform called DepoVax(TM) (DPX) was developed. C3 tumor-c...

2017
Patrick M Dillon Gina R Petroni Mark E Smolkin David R Brenin Kimberly A Chianese-Bullock Kelly T Smith Walter C Olson Ibrahim S Fanous Carmel J Nail Christiana M Brenin Emily H Hall Craig L Slingluff

BACKGROUND Breast cancer remains a leading cause of cancer death worldwide. There is evidence that immunotherapy may play a role in the eradication of residual disease. Peptide vaccines for immunotherapy are capable of durable immune memory, but vaccines alone have shown sparse clinical activity against breast cancer to date. Toll-like receptor (TLR) agonists and helper peptides are excellent a...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید